New Zofran Lawsuit Filed in Alabama

A woman who alleges her son suffered serious birth defects as a result of prenatal exposure to Zofran has filed a lawsuit against GlaxoSmithKline.

Thursday, April 9, 2015 - A new Zofran lawsuit was filed against the drug's maker, GlaxoSmithKline, on April 1, 2015 in U.S. District Court in the Northern Alabama District. The plaintiff has filed the lawsuit on behalf of her son, who was born in 2006 with a range of severe birth defects and health problems. Asserting that the company knew or should have known that Zofran was not safe for developing fetuses, the lawsuit aims to hold the company accountable for the harm and suffering caused, according to the complaint filed. The child suffers from a narrow pallet, extra fingers, a seizure disorder, a distended kidney, a chromosomal defect, developmental delays including the inability to speak, and glaucoma, all of which the plaintiff says are linked to Zofran exposure. This is one of several Zofran birth defect lawsuits have been filed around the country in the early months of 2015.

More Recent Zofran Birth Defects Lawsuit News:

• Australian Zofran Study Finds Increased Risk Of Birth Defects | 1/27/2016
• GSK Files To Dismiss All Zofran MDL Lawsuits | 1/20/2016
• Diversity In Severity Of Defects Allegedly Caused By Zofran | 1/13/2016
• Zofran MDL Lawsuits Top 200 Total | 1/6/2016
• Questions Of Fact In Zofran MDL Lawsuits | 12/30/2015
• Direct Filing Allowed In Zofran MDL | 12/23/2015
• Total Zofran Lawsuits Expected To Top 200 | 12/16/2015
• Idaho Lawsuit Claims GSK Didn't Test Zofran On Humans | 12/9/2015
• Doctors Still Able To Prescribe Zofran For Morning Sickness | 12/2/2015
• Updates for Zofran MDL Heading Into Month Two Of Consolidation | 11/25/2015
• Zofran Birth Defect Lawsuits Top 100 Nationwide | 11/18/2015
• New Zofran Lawsuit Filed In Idaho | 11/11/2015
• First Zofran Status Conference Set For November 17 | 11/4/2015
• New Alabama Zofran Lawsuit Filed | 10/28/2015
• Four Separate Plaintiffs File Zofran Claim Together | 10/21/2015
• Zofran Lawsuits Consolidated by JPML | 10/14/2015
• Oregon Family Files New Zofran Lawsuit | 10/7/2015
• Toronto Star Zofran Report Significant In Plaintiffs' Arguments | 9/30/2015
• Lawsuits Grow Nationwide As MDL Decision Nears | 9/16/2015
• Two New Zofran Lawsuits Claim Birth Defects From 1990's | 9/9/2015
• New Zofran Lawsuit Claims GSK Drug Led To Child's Single Kidney | 9/2/2015
• JPML Will Hear GSK Motion To Transfer In October | 8/26/2015
• Zofran Lawsuits Top 30 Nationwide As GSK Spokesperson Denies Liability | 8/19/2015
• Two New Zofran Lawsuits Filed In Illinois And North Dakota | 8/12/2015
• FDA Plans Public Meeting Regarding Off-Label Medication | 8/5/2015
• New Report Released Intended To Advise Potential Zofran Plaintiffs. | 7/29/2015
• New Zofran Lawsuits Filed In Alabama and Louisiana | 7/22/2015
• Zofran Lawsuits Expected To Rise After MDL Request | 7/15/2015
• GSK Files Motion To Transfer 12 Zofran Lawsuits Into MDL | 7/8/2015
• Research Linking Zofran and Birth Defects Prevalent Throughout US | 7/1/2015
• Families Around U.S. Filing Claims On Behalf Of Children Affected By Zofran | 6/22/2015
• New Zofran Lawsuit In Ohio Claims Drug Caused Death of Daughter | 6/14/2015
• Plaintiffs Continue To File New Zofran Lawsuits | 6/10/2015

No-Cost, No-Obligation Zofran Birth Defect Lawsuit Case Review If You or a Loved One Has Had a Baby with Birth Defects

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.